PDB ID 1C3D     CHAIN A
Protein name C3D
Uniprot Accession P01024
The number of similar proteins 25
The number of binding states 13
The number of binding partners 9

Coloring

Unicolor (beige)

The number of binding partners

Group

Binding
state
Binding partners
1C3D (CHAIN: A)
1 Monomeric state
2 C8LN82  
3 P20023  
4 P01024  
5 P08603  
6 Q99UV2  
7 P11215  
8 Q587F5  
9 P20023   P20023  
10 P01024   P08603  
11 P01024   Q931F4  
12 7UE9   7UE9  
13 P68799   P36980  

Downdload

Format:

Molecule viewer


Only interaction residues
#binding
partners
  4
  3
  2
  1
  0

Sequence information

1   MLDAERLKHL   IVTPSGAGEQ   NMIGMTPTVI   AVHYLDETEQ   WEKFGLEKRQ   50
51   GALELIKKGY   TQQLAFRQPS   SAFAAFVKRA   PSTWLTAYVV   KVFSLAVNLI   100
101   AIDSQVLCGA   VKWLILEKQK   PDGVFQEDAP   VIHQEMIGGL   RNNNEKDMAL   150
151   TAFVLISLQE   AKDICEEQVN   SLPGSITKAG   DFLEANYMNL   QRSYTVAIAG   200
201   YALAQMGRLK   GPLLNKFLTT   AKDKNRWEDP   GKQLYNVEAT   SYALLALLQL   250
251   KDFDFVPPVV   RWLNEQRYYG   GGYGSTQATF   MVFQALAQYQ   KDAP   300

Variants

Residue AA Source /
dbSNP
Clinical
Significance
Allele
Frequency
(> 0.0001)
AlphaMissense
pathogenicity
Disease name
20_GLN HIS 8.3kJPN
chr19:6694557
-
- 0.0001 0.9919 -
24_GLY CYS 8.3kJPN
chr19:6694547
-
- 0.0003 0.4243 -
41_TRP ARG ClinVar
chr19:6694496
-
Likely pathogenic - - Atypical hemolytic-uremic syndrome [MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134]
41_TRP ARG ClinVar
chr19:6694496
-
Likely pathogenic - - Atypical hemolytic-uremic syndrome [MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134]
49_ARG LEU VAR_063655
-
LP/P - 0.8973 Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925]
88_TYR TER ClinVar
chr19:6693082
-
Pathogenic - - Complement component 3 deficiency [MONDO:MONDO:0013417,MedGen:C3151071,OMIM:613779,Orphanet:280133]
101_ALA VAL VAR_063216
rs121909584
LP/P - 0.1579 Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925]
101_ALA VAL ClinVar
chr19:6693044
rs121909584
Likely pathogenic - 0.1579 Atypical hemolytic-uremic syndrome with C3 anomaly|Atypical hemolytic-uremic syndrome [MONDO:MONDO:0013043,MedGen:C2752037,OMIM:612925,Orphanet:2134|MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134]
101_ALA ASP ClinVar
chr19:6693044
-
Likely pathogenic - - Atypical hemolytic-uremic syndrome [MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134]
122_ASP ASN VAR_063217
rs121909585
LP/P - 0.1388 Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925]
123_GLY ARG ClinVar
chr19:6692979
-
Likely pathogenic - - Atypical hemolytic-uremic syndrome [MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134]
141_ARG GLN 8.3kJPN
chr19:6690728
rs777904423
- 0.0001 0.0836 -
151_THR ALA 8.3kJPN
chr19:6690699
-
- 0.0001 0.849 -
164_ILE THR ClinVar
chr19:6690659
rs1918142335
Pathogenic/Likely pathogenic - 0.2583 Atypical hemolytic-uremic syndrome|not provided [MONDO:MONDO:0016244,MedGen:C2931788,Orphanet:2134|MedGen:C3661900]
165_CYS TRP VAR_063218
-
LP/P - 0.9941 Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925]
168_GLN LYS VAR_063219
rs2145404130
LP/P - 0.0872 Hemolytic uremic syndrome, atypical, 5 (AHUS5) [MIM:612925]
231_GLY ASP VAR_019207
rs11569534
LB/B - 0.1152 -
231_GLY ASP gnomAD
chr19:6686274
rs11569534
- 0.00147915 0.1152 -
259_VAL ILE gnomAD
chr19:6686191
rs537300095
- 0.000258453 0.0874 -
259_VAL ILE 8.3kJPN
chr19:6686191
rs537300095
- 0.0001 0.0874 -
270_GLY ALA 8.3kJPN
chr19:6686157
-
- 0.0001 0.3941 -
277_GLN TER ClinVar
chr19:6686137
-
Pathogenic - - not provided [MedGen:C3661900]
278_ALA SER 8.3kJPN
chr19:6685157
-
- 0.0001 0.1662 -
289_TYR TER ClinVar
chr19:6685122
-
Likely pathogenic - - Complement component 3 deficiency [MONDO:MONDO:0013417,MedGen:C3151071,OMIM:613779,Orphanet:280133]
293_ALA THR 8.3kJPN
chr19:6685112
rs556995881
- 0.0001 0.0857 -
(Powered by wupsivus)

Reference

PiSite: a database of protein interaction sites using multiple binding states in the PDB, Miho Higurashi, Takashi Ishida and Kengo Kinoshita, Nucleic Acids Research 2009 37(Database issue):D360-D364

COPYRIGHTc2008-2019 Miho Higurashi, Takashi Ishida and Kengo Kinoshita. All rights reserved.